Legend Biotech Corp Stock Price To Book
| LEGN Stock | USD 39.75 0.39 0.97% |
Legend Biotech Corp fundamentals help investors to digest information that contributes to Legend Biotech's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend Biotech stock.
As of the 22nd of November 2024, Price To Book Ratio is likely to drop to 8.04. Legend | Price To Book |
Legend Biotech Corp Company Price To Book Analysis
Legend Biotech's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Legend Biotech Price To Book | 6.53 X |
Most of Legend Biotech's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Legend Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Legend Biotech is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Price To Book. Since Legend Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Legend Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Legend Biotech Corp has a Price To Book of 6.5336 times. This is 74.56% lower than that of the Biotechnology sector and 8.17% higher than that of the Health Care industry. The price to book for all United States stocks is 31.3% higher than that of the company.
Legend Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend Biotech's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics of similar companies.Legend Biotech is currently under evaluation in price to book category among its peers.
Legend Biotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Legend Biotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Legend Biotech's managers, analysts, and investors.Environmental | Governance | Social |
Legend Fundamentals
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.67) % | ||||
| Operating Margin | (0.44) % | ||||
| Current Valuation | 6.43 B | ||||
| Shares Outstanding | 183.45 M | ||||
| Shares Owned By Insiders | 1.30 % | ||||
| Shares Owned By Institutions | 51.20 % | ||||
| Number Of Shares Shorted | 15.86 M | ||||
| Price To Book | 6.53 X | ||||
| Price To Sales | 14.02 X | ||||
| Revenue | 285.14 M | ||||
| Gross Profit | (284.01 M) | ||||
| EBITDA | (477.87 M) | ||||
| Net Income | (518.25 M) | ||||
| Cash And Equivalents | 791.26 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 328.67 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 6.08 X | ||||
| Cash Flow From Operations | (393.28 M) | ||||
| Short Ratio | 12.18 X | ||||
| Earnings Per Share | (1.92) X | ||||
| Target Price | 82.55 | ||||
| Number Of Employees | 2.4 K | ||||
| Beta | 0.11 | ||||
| Market Capitalization | 7.29 B | ||||
| Total Asset | 1.85 B | ||||
| Retained Earnings | (1.48 B) | ||||
| Working Capital | 1.28 B | ||||
| Net Asset | 1.85 B |
About Legend Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Legend Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Legend Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Legend Stock
| 0.74 | ME | 23Andme Holding | PairCorr |
| 0.9 | VALN | Valneva SE ADR Downward Rally | PairCorr |
| 0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Legend Stock
| 0.48 | KZR | Kezar Life Sciences | PairCorr |
| 0.44 | MLYS | Mineralys Therapeutics, Downward Rally | PairCorr |
| 0.43 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.37 | RNXT | RenovoRx | PairCorr |
| 0.34 | NXGLW | NexGel Warrant | PairCorr |
The ability to find closely correlated positions to Legend Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend Biotech Corp to buy it.
The correlation of Legend Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Legend Biotech Piotroski F Score and Legend Biotech Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.